Diarrhea News and Research

Latest Diarrhea News and Research

Drinking coffee regularly may help prevent irritable bowel syndrome

Study reveals that coffee consumption is associated with a reduced risk of developing irritable bowel syndrome (IBS), as determined by a systematic review and meta-analysis of global studies.

14 Nov 2023

New research reveals broccoli sprouts may alleviate Crohn's disease symptoms in youth

The impact of broccoli sprouts and its role in resolving Crohn’s disease symptoms.

14 Nov 2023

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

13 Nov 2023

UK regulator approves a diabetes drug for weight management in obese and overweight patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (8 November 2023) authorised via a national application route, a new indication for the diabetes medicine, Mounjaro (tirzepatide), for weight loss and weight management in adults aged 18 and over.

13 Nov 2023

Diverse gut bacteria could help fight cryptosporidiosis

The severity of a diarrheal disease could be down to the bacteria in your gut - according to new research from the University of East Anglia.

10 Nov 2023

Broccoli sprouts diet protects mice from Crohn's disease, study shows

High fiber diets, like those that include broccoli sprouts or other cruciferous vegetables, may reduce disease symptoms and improve quality of life in patients with inflammatory bowel disease (IBD), according to a study conducted in mice.

9 Nov 2023

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Patients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer if they are treated with a new drug called pyrotinib, according to results from the longest follow-up of the PHOEBE randomized clinical trial in China.

8 Nov 2023

Blood tests can detect inflammatory bowel disease years before symptoms appear

Researchers at the Francis Crick Institute and Aalborg University in Copenhagen have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn's disease and up to three years before a diagnosis of ulcerative colitis.

7 Nov 2023

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Karl Klose, director of The South Texas Center for Emerging Infectious Diseases (STCEID) and the Robert J. Kleberg, Jr. and Helen C. Kleberg College of Sciences Endowed Professor, coauthored a research article with Cameron Lloyd '23, a UTSA doctoral student who graduated in August with a Ph.D. in molecular microbiology and immunology under the guidance of Klose.

7 Nov 2023

Fresh risks in ready-to-eat produce: Study reveals how common pathogens lurk in our salads

This research paper delves into the risks of contamination in ready-to-eat fruits and vegetables by enteric pathogens like E. coli, Salmonella, and Listeria, which can lead to foodborne illnesses. It also explores the contamination sources and plant-pathogen interactions, emphasizing the importance of improved safety measures in the food supply chain.

6 Nov 2023

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Comprehensive review unravels the complexities of long COVID, spanning pathophysiology to management strategies, and underscores the need for targeted therapies and early diagnosis.

5 Nov 2023

New treatment breakthrough: Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

The safety and efficacy of treating human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with pyrotinib.

2 Nov 2023

Current jargon on antibiotic resistance fails to stick or scare, study finds

Researchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like "AMR" and "antimicrobial resistance" are poorly remembered and do not evoke sufficient risk perception, highlighting the need for improved public health messaging.

29 Oct 2023

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

The therapeutic potential of resveratrol, a red grape polyphenol.

25 Oct 2023

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

22 Oct 2023

Early eating habits shape celiac disease risk in young kids, study shows

This long-term study reveals that dietary patterns in the first two years of life can significantly influence the risk of developing celiac disease autoimmunity (CDA) and celiac disease in genetically predisposed children. High intake of vegetable fats and milk at 9 months reduced CDA risk, while at 24 months, certain foods like wheat and vegetable fats increased the risk, emphasizing the role of non-gluten dietary factors.

17 Oct 2023

Multidrug-resistant E.coli outcompete harmless strains to take over the gut, study reveals

Different strains of E.coli can outcompete one another to take over the gut, a new study reveals.

17 Oct 2023

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

New orally-administered GLP-1 receptor agonists danuglipron and orforglipron show promise in treating type 2 diabetes and obesity, according to a systematic review. While effective in glycemic control and weight reduction, these drugs come with gastrointestinal side effects that may lead to treatment discontinuation.

17 Oct 2023

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

In a groundbreaking 84-week-long study, researchers found that tirzepatide, a medication initially designed for treating type 2 diabetes, significantly bolstered weight loss in overweight and obese patients already on intensive lifestyle programs. While the drug showed promise in further reducing body weight and improving cardiometabolic factors, mild to moderate gastrointestinal side effects were the most common drawback.

16 Oct 2023

UNLV scientists discover way to interfere with virulence protein in Shigella

The legendary Alexander Fleming, who famously discovered penicillin, once said "never to neglect an extraordinary appearance or happening."

16 Oct 2023

Diarrhea News and Research

Latest Diarrhea News and Research

Drinking coffee regularly may help prevent irritable bowel syndrome

New research reveals broccoli sprouts may alleviate Crohn's disease symptoms in youth

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

UK regulator approves a diabetes drug for weight management in obese and overweight patients

Diverse gut bacteria could help fight cryptosporidiosis

Broccoli sprouts diet protects mice from Crohn's disease, study shows

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Blood tests can detect inflammatory bowel disease years before symptoms appear

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Fresh risks in ready-to-eat produce: Study reveals how common pathogens lurk in our salads

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

New treatment breakthrough: Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

Current jargon on antibiotic resistance fails to stick or scare, study finds

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Early eating habits shape celiac disease risk in young kids, study shows

Multidrug-resistant E.coli outcompete harmless strains to take over the gut, study reveals

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

UNLV scientists discover way to interfere with virulence protein in Shigella

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Diarrhea News and Research

Latest Diarrhea News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in